Sign up to save your podcasts
Or
Share Targeted Talks
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Targeted Talks
Targeted Talks episodes
- S3 Ep6: Examining the Non-Hodgkin Lymphoma Treatment ParadigmYazan Samhouri, MD, discusses the exciting new agents for the treatment of non-Hodgkin lymphoma, the clinical trials that support their use, and hopes for the future of treatment.13 min
- S3 Ep5: The Road to Improving Diffuse Large B-Cell Lymphoma TreatmentIn season 3, episode 5 of Targeted Talks, Thomas Habermann, MD, discusses the latest advances in the treatment of diffuse large B-cell lymphoma.9 min
- S3 Ep4: Better Strategies for the Treatment of High-Risk Chronic Lymphocytic LeukemiaIn season 3, episode 4 of Targeted Talks, Alexey Danilov, MD, PhD, discusses the shift toward utilizing cellular therapy to treat high-risk patients with chronic lymphocytic leukemia.11 min
- S3 Ep3: Unpacking the New Recommendations for Early-Stage Breast Cancer ManagementIn season 3, episode 3 of Targeted Talks, William J. Gradishar, MD, discusses the latest version of the NCCN Clinical Practice Guidelines for managing early-stage breast cancer.14 min
- S3 Ep2: Advances and Pending Innovations in the Treatment of SarcomaMark Agulnik, MD, City of Hope Comprehensive Cancer Center joins Targeted Oncology for a discussion about the sarcoma treatment landscape and pending innovations under investigation in clinical trials.19 min
- S3 Ep1: A Look Inside the Toolbox for BRAF-Mutant Metastatic MelanomaIn season 3, episode 1 of Targeted Talks, Michael A. Postow, MD, discusses available targeted agents for BRAF-mutant melanoma and ongoing clinical questions about treating the disease.10 min
- S2 Ep10: Treating Sarcoma With a Multidisciplinary ApproachSandra P. D'Angelo, MD and Katherine Poruk, MD17 min
- S2 Ep9: Sequencing Therapy for Metastatic Castration-Resistant Prostate CancerIn season 2, episode 9 of Targeted Talks, Sandy Srinivas, MD and Nicholas J. Vogelzang, MD, discuss he optimal sequencing of therapies for a specific patient with metastatic castration-resistant prostate cancer.18 min
- S2 Ep8: New Targeted Therapies in Renal Cell CarcinomaIn season 2, episode 8 of “Targeted Talks,” Thomas Hutson, DO, PharmD, and Rana R. McKay, MD, of UC San Diego Health, discussed the renal cell carcinoma paradigm and challenges to overcome in the future.42 min
- S2 Ep7: Recent Developments in Immunotherapy for MelanomaIn season 2, episode 8 of Targeted Talks, Jeff Yorio, MD, and Douglas Johnson, MD, MSCI, joins us for a talk around recent advances in immunotherapy for melanoma.25 min
About Targeted Talks
From the publisher's feed
Targeted Talks is a podcast series from Targeted Oncology featuring one-on-one conversations with leading oncologists about the issues shaping cancer care today. Each episode explores the real-world challenges clinicians face alongside discussions of emerging research across tumor types. Whether unpacking new data, translating conference highlights into clinical context, or addressing the practical realities of oncology practice, Targeted Talks delivers timely, actionable conversations designed for today's oncology professionals.
For more visit: https://www.targetedonc.com/podcasts
More shows like Targeted Talks
Planet Money
30,577 Listeners
Interesting Times
7,114 Listeners